Hikma Pharmaceuticals PLC (HIK.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 10:36AM BST. Market open.
| Previous close | 1,958.00 |
| Open | 1,969.00 |
| Bid | 1,959.00 x 0 |
| Ask | 1,961.00 x 0 |
| Day's range | 1,946.00 - 1,981.00 |
| 52-week range | 1,711.00 - 2,222.00 |
| Volume | |
| Avg. volume | 535,115 |
| Market cap | 4.347B |
| Beta (5Y monthly) | 0.44 |
| PE ratio (TTM) | 29.24 |
| EPS (TTM) | 0.67 |
| Earnings date | N/A |
| Forward dividend & yield | 0.57 (2.93%) |
| Ex-dividend date | 21 Mar 2024 |
| 1y target est | 22.80 |
Simply Wall St.With 52% institutional ownership, Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst the big guns
Key Insights Significantly high institutional ownership implies Hikma Pharmaceuticals' stock price is sensitive to...
Fool.co.ukI’m considering these 3 undervalued pharma stocks to buy for my portfolio in April
I want to increase my exposure to the pharmaceuticals industry this year, so I've been looking for undervalued stocks to buy with strong growth potential. The post I’m considering these 3 undervalued pharma stocks to buy for my portfolio in April appeared first on The Motley Fool UK.
- Simply Wall St.
Optimism around Hikma Pharmaceuticals (LON:HIK) delivering new earnings growth may be shrinking as stock declines 3.3% this past week
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
© 2024 Yahoo. All rights reserved.